Translational Psychiatry

Our research focuses on the pathophysiology of mental disorders, their early detection, and their prevention and treatment.


Motivational brief interventions for adolescents and young adults with Internet use disorders: A randomized-controlled trial
Neurobiologically Based Stratification of Recent-Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic Phenotypes
Influence of chronotype on the incidence and severity of perinatal depression in the “Life-ON” study
Identification of texture brain MRI abnormalities on clinical high-risk patients using explainable artificial intelligence
Auditory perceptual and confidence decisions in humans and artificial neural networks
Artificial intelligence in suicide prevention – using deep learning methods to interpret psychiatric free text documentation


We strive to improve the prediction of psychotic disorders in young high-risk patients, and investigate the neurofunctional mechanisms and efficacy of potential innovative treatments such as cannabinoids and psychedelics. We apply a variety of methods in pharmacological and clinical studies.


About us

We are an interdisciplinary team consisting of scientists and health care personnel from the fields of psychiatry, psychology, physicians/medicine, neurosurgery, neurophysiology, mathematics, and biomedical engineering. We drive innovative, translational science forward by combining our diverse set of expertise.



Our research combines clinical excellence in early intervention with extensive expertise in conducting interdisciplinary research in several key areas revolving around psychotic disorders. These include their prediction, neurofunctional and cognitive mechanisms, and efficacy of potential innovative treatments. We run a variety of pharmacological, clinical, and intervention studies that will support the development of tools for individualized prediction and treatment.

Scroll to Top